University of Arizona Cancer Center
Tucson, Arizona, 85719, United States
NCT Number: NCT05952492
The purpose of this study is to determine the feasibility of recruiting young adult cancer survivors from across the nation and to explore the impact of an eHealth group intervention on psychosocial health in this population.
Looking for future studies?
Notify MeStudy investigators will conduct a single-arm pilot trial in which a 10 week eHealth group intervention will be delivered via a study website. We will use a multi-pronged approach to recruit young adult cancer survivors from across the country. Study participants will attend weekly group meetings with a trained facilitator to receive the manualized intervention over the course of 10 weeks.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will attend group sessions with a trained facilitator held over videoconference. Sessions will each last 2 hours and be held once weekly for 10 weeks. Sessions will include stress management skills training and health education content.
Time frame: Through study completion, an average of 1 year
Recruitment will be considered feasible if ≥40% of eligible survivors enroll in the study.
Time frame: Baseline and immediately after the intervention
Participants will complete the 27-item Functional Assessment of Cancer Therapy - General. Scores range from 0 to 108, with higher scores reflecting better quality of life.
Time frame: Baseline and immediately after the intervention
Participants will complete subscales from the Measure of Current Status. Subscale scores range from 0 to 8, 0 to 12, or 0 to 20 depending on the subscale. Higher scores indicate more of the construct being assessed.
Time frame: Baseline and immediately after the intervention
Participants will complete the 22-item Impact of Event Scale-Revised. Scores range from 0 to 88, with higher scores indicating greater cancer-related distress.
Time frame: Baseline and immediately after the intervention
Participants will complete the Brief Coping Orientation to Problems Experienced scale, which yields 14 two-item subscales. Subscale scores range from 2 to 8, with higher scores indicating greater usage of the coping strategy being assessed.
Time frame: Baseline and immediately after the intervention.
Participants will complete the Generalized Anxiety Disorder-7. Given the sample size, the investigators will focus on effect sizes rather than statistical significance.
The Unabbreviated scale title is the Generalized Anxiety Disorder-6. Minimum value=0. Maximum value=21. Higher scores=worse.
Time frame: Baseline and immediately after the intervention.
Participants will complete the Patient Health Questionnaire-9. Given the sample size, the investigators will focus on effect sizes rather than statistical significance.
The Unabbreviated scale title is the Patient Health Questionnaire-9. Minimum value=0. Maximum value=27. Higher scores=worse.
Time frame: Baseline and the final week of the intervention
Participants will wear a wearable sensor for at least 1 week.
University of Arizona
Other
Improving Young Adult Cancer Survivors' Mental Health with an EHealth Group Intervention
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05364372
Behavior, Cancer
Tucson, Arizona, United States
View Trial DetailsNCT01445483
Brain Diseases, Brain Metastasis
Bethesda, Maryland, United States
View Trial DetailsNCT00038727
Body Weight, CVD
Rockville, Maryland, United States
View Trial DetailsNCT03556384
Brain Diseases, Cancer
La Jolla, California, United States
View Trial Details